Initial Clinical Experience With ClearPoint SmartFrame Array-Aided Stereotactic Procedures.BACKGROUND
 The ClearPoint SmartFrame Array (ClearPoint Neuro, Inc., Solana Beach, CA) system consists of a magnetic resonance imaging compatible frame supported by a customized neuro navigation software. 
ClearPoint SmartFrame Array
The ClearPoint SmartFrame Array (ClearPoint Neuro, Inc., Solana Beach, CA) system consists of a magnetic resonance imaging compatible frame supported by a customized neuro navigation software. 
ClearPoint Neuro
This system received U.S. Food and Drug Administrationclearance for clinical use in January 2021. 
U.S. Food and Drug Administration
Clinical and procedural data were recorded and compared to data obtained from prior cases with SmartFrame XG.


 The average stereotaxis time for the SmartFrame Array-aided single trajectory procedure was 80 ± 9.5 minutes, which compared favorably to that required for the earlier generation SmartFrame XG frame (111.5 ± 16.5 minutes; P < 0.01).  The unique Array design supported stereotactic procedures that cannot be easily achieved with the previous SmartFrame XG frame.



SmartFrame XG